Other observations casting doubt on skin lesions as the FGF23 source are that the vast majority of patients with congenital nevi do not have hypophosphatemia and that patients with FGF23-mediated hypophosphatemia have concomitant dysplastic bone lesions (2). This evidence concerns the gene FGF23 and hypophosphatemia.